Meritage Portfolio Management Gilead Sciences, Inc. Transaction History

Meritage Portfolio Management

$1.63 Billion
Q3 2024

A detailed history of Meritage Portfolio Management transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Meritage Portfolio Management holds 58,603 shares of GILD stock, worth $5.29 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

58,603

Previous 61,050 4.01%

Holding current value

$5.29 Million

Previous $4.19 Million 17.28%

% of portfolio

0.3%

Previous 0.26%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$66.59 - $83.99 $162,945 - $205,523	-2,447 Reduced 4.01%	58,603 $4.91 Million
Q2 2024 Aug 08, 2024	SELL	$63.15 - $72.88 $72,938 - $84,176	-1,155 Reduced 1.86%	61,050 $4.19 Million
Q1 2024 Apr 29, 2024	SELL	$71.58 - $87.29 $240,007 - $292,683	-3,353 Reduced 5.11%	62,205 $4.56 Million
Q4 2023 Feb 02, 2024	SELL	$73.27 - $83.09 $25,058 - $28,416	-342 Reduced 0.52%	65,558 $5.31 Million
Q3 2023 Oct 30, 2023	SELL	$73.94 - $80.67 $66,693 - $72,764	-902 Reduced 1.35%	65,900 $4.94 Million
Q2 2023 Jul 31, 2023	BUY	$76.01 - $86.7 $178,167 - $203,224	2,344 Added 3.64%	66,802 $5.15 Million
Q1 2023 Apr 25, 2023	BUY	$77.31 - $88.08 $120,680 - $137,492	1,561 Added 2.48%	64,458 $5.35 Million
Q4 2022 Feb 01, 2023	BUY	$62.32 - $89.47 $126,447 - $181,534	2,029 Added 3.33%	62,897 $5.4 Million
Q3 2022 Oct 25, 2022	BUY	$59.54 - $68.01 $161,412 - $184,375	2,711 Added 4.66%	60,868 $3.76 Million
Q2 2022 Jul 25, 2022	BUY	$57.72 - $65.01 $52,063 - $58,639	902 Added 1.58%	58,157 $3.6 Million
Q1 2022 Apr 25, 2022	BUY	$57.92 - $72.58 $850,902 - $1.07 Million	14,691 Added 34.52%	57,255 $3.4 Million
Q4 2021 Jan 28, 2022	SELL	$64.88 - $73.64 $196,262 - $222,761	-3,025 Reduced 6.64%	42,564 $3.09 Million
Q3 2021 Oct 26, 2021	SELL	$67.69 - $73.03 $8,664 - $9,347	-128 Reduced 0.28%	45,589 $3.18 Million
Q2 2021 Jul 26, 2021	BUY	$63.47 - $69.35 $12,884 - $14,078	203 Added 0.45%	45,717 $3.15 Million
Q1 2021 Apr 27, 2021	BUY	$60.0 - $68.46 $2.28 Million - $2.61 Million	38,066 Added 511.09%	45,514 $2.94 Million
Q3 2020 Oct 26, 2020	SELL	$62.1 - $78.08 $5,216 - $6,558	-84 Reduced 1.12%	7,448 $471,000
Q2 2020 Jul 27, 2020	SELL	$72.34 - $84.0 $3.73 Million - $4.34 Million	-51,610 Reduced 87.26%	7,532 $580,000
Q1 2020 Apr 27, 2020	SELL	$62.63 - $80.22 $20,166 - $25,830	-322 Reduced 0.54%	59,142 $4.42 Million
Q4 2019 Jan 27, 2020	BUY	$61.62 - $67.78 $3.19 Million - $3.5 Million	51,696 Added 665.5%	59,464 $3.86 Million
Q3 2019 Oct 25, 2019	BUY	$62.51 - $69.0 $20,003 - $22,080	320 Added 4.3%	7,768 $492,000
Q1 2019 Apr 25, 2019	SELL	$62.53 - $70.05 $1,563 - $1,751	-25 Reduced 0.33%	7,448 $484,000
Q4 2018 Jan 25, 2019	BUY	$60.54 - $79.0 $1,513 - $1,975	25 Added 0.34%	7,473 $467,000
Q4 2017 Jan 29, 2018	SELL	$71.15 - $83.52 $265,033 - $311,112	-3,725 Reduced 33.34%	7,448 $533,000
Q3 2017 Oct 16, 2017	BUY	$72.11 - $85.47 $805,685 - $954,956	11,173	11,173 $906,000

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meritage Portfolio Management, based on Form 13F filings with the SEC.

News

Stay updated on Meritage Portfolio Management with notifications on news.

Account

Meritage Portfolio Management Gilead Sciences, Inc. Transaction History